1. Top
  2. Abount us

Abount us

Member

Katsuhisa HORIMOTO, Ph.D.

Board Director CEO, Founder

Tokyo Univ. of Science, Ph.D.(Biophysics),The Univ. of Tokyo, AIST
>130 peer-reviewed papers on computational systems biology, 8 parents of algorithms.
2017/9 Co-founder of SOCIUM.
2019/4 Visiting Professor of Saitama Medical Univ.

Michio SHIGEMORI, MBA

Board Director, CFO

Meiji Univ., MBA
Worked in global treasury services at Bank of America and treasury operations at BASF Metals Japan.
2022/6 Joined SOCIUM
2024/1 Board Director CFO

Noboru IWAKAMI, Ph.D.

Board Director, CMO

Waseda Univ., Ph.D.(Human Science)
Worked at Toyama Chemical Co., Ltd., in charge of research and development in the field of psychiatry and neurology.
2021/11 Joined SOCIUM
2024/1 Board Director CMO

Makoto MIURA

Audit & Supervisory Board Member

Graduated from the Univ. of Tokyo, Faculty of Economics.
Worked in U.S. GAAP auditing of megabanks at Deloitte Touche Tohmatsu LLC and Established Makoto Miura CPA Office.
2018/10 Joined SOCIUM

Company Profile

Segments ① Drug repositioning platform based on a combination of proprietary technologies, and the world’s first phosphorylation analysis technology
  • ・Drug Repurposing(Indication Hopping)
  • ・Phosphorylation Analysis(activating pathway and kinase analysis)
  • ・MOA Clarification
  • ・Target Prediction
  • ・Stratification Marker Exploration
  • ・in vitro, vivo assay
② Joint development of drug seeds discovered using these technologies
Foundation date Sep. 2017
CEO Katsuhisa Horimoto
Office 17-1, Nihonbashi-Kabuto-cho, Chuo-ku, Tokyo 103-0026, Japan
Laboratory AIST Tokyo Waterfront, 2-4-7, Aomi, Koto-ku, Tokyo 135-0064, Japan

Career

Click here for Career Information